Effect of Losartan on Mitral Valve Changes After Myocardial Infarction.

about

Mitral Valve Adaptation to Isolated Annular Dilation: Insights Into the Mechanism of Atrial Functional Mitral Regurgitation.

P2860

Q49721037-19EF5517-B8F9-4A35-AA43-EE5B0AF57B01

P2860

Effect of Losartan on Mitral Valve Changes After Myocardial Infarction.

Item

http://www.wikidata.org/entity/Q47875235

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Effect of Losartan on Mitral Valve Changes After Myocardial Infarction.

@en

Effect of Losartan on Mitral Valve Changes After Myocardial Infarction.

@nl

type

Item

label

Effect of Losartan on Mitral Valve Changes After Myocardial Infarction.

@en

Effect of Losartan on Mitral Valve Changes After Myocardial Infarction.

@nl

prefLabel

Effect of Losartan on Mitral Valve Changes After Myocardial Infarction.

@en

Effect of Losartan on Mitral Valve Changes After Myocardial Infarction.

@nl

P1476

Effect of Losartan on Mitral Valve Changes After Myocardial Infarction.

@en

P2093

Alain Carpentier

http://www.w3.org/2001/XMLSchema#string

Albert A Hagège

http://www.w3.org/2001/XMLSchema#string

Catherine Szymanski

http://www.w3.org/2001/XMLSchema#string

Emmanuel Messas

http://www.w3.org/2001/XMLSchema#string

J Luis Guerrero

http://www.w3.org/2001/XMLSchema#string

Jacob P Dal-Bianco

http://www.w3.org/2001/XMLSchema#string

James S Titus

http://www.w3.org/2001/XMLSchema#string

Jill Wylie-Sears

http://www.w3.org/2001/XMLSchema#string

Jonathan Beaudoin

http://www.w3.org/2001/XMLSchema#string

Leducq Transatlantic Mitral Network

http://www.w3.org/2001/XMLSchema#string

P2860

Mitral valve disease--morphology and mechanisms.

Angiotensin II blockade and aortic-root dilation in Marfan's syndrome

Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation

Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation.

Mitral-valve repair versus replacement for severe ischemic mitral regurgitation.

Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis.

Losartan inhibits endothelial-to-mesenchymal transformation in mitral valve endothelial cells by blocking transforming growth factor-β-induced phosphorylation of ERK.

Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.

P304

1232-1244

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2017.07.734

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Joyce Bischoff

Elena Aikawa

Dae-Hee Kim

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28859786

http://www.w3.org/2001/XMLSchema#string

P932

5679094

http://www.w3.org/2001/XMLSchema#string

Effect of Losartan on Mitral Valve Changes After Myocardial Infarction.

about

P2860

P2860

Effect of Losartan on Mitral Valve Changes After Myocardial Infarction.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932